Hydrochlorothiazide
It inhibits the active reabsorption of sodium, chiefly in the distal renal tubule, thus increasing the excretion of sodium, chloride & water. Cardiac output and both extracellular & plasma volume decrease and during longterm treatment peripheral vascular resistance diminishes. Combined treatment with other drugs used for the treatment of hypertension potentiates the blood pressure lowering effect.Hypertension, heart failure, oedema due to heart falure, mild to moderate renal or hepatic failure. Renal diabetes insipidus. Idopathic hypercalciuria.
Hypertension: 25-50 mg 1-2 imes. Heart failure & oedema : 25-75 mg daily in 1-2 doses. Children: 2 mg/kg/day. Renal diabetes insipidus: Initially 100 mg daily in 2-4 doses.
Anuria, severe renal & hepatic failure, hypersensitivity, refractory hypokalaemia & hyponatraemia, hypercalcaemia & symptomatic hyperuricaemia.
nervousness, muscle spasms, cardiac arrhythmias, serum electrolyte balance, diabetes. Paediatrics: Usually not prescribed. Pregnancy: Contraindicated in case of toxaemia of pregnancy. Lactations: The drug passes into breast milk. Elderly: Increased likelihood of adverse effects.
Reduced glucose tolerance, hyper- uricaemia, hypokalaemia.
Potentiates anti-hypertensives, caution in patient taking digoxin, increased risk of hypokalemia with corticosteroids, dose of oral antidiabetic agents may need to be raised, probenecid competitively inhibits tubular secretion.